Influence of rosuvastatin on the NAD(P)H oxidase activity in the retina and electroretinographic response of spontaneously hypertensive rats

British Journal of Pharmacology

Volumn 151, Issue 7, 2007, Pages 979-986

  Sicard, P ^a   Acar, N ^b   Gregoire S ^b   Lauzier, B ^a   Bron, A M ^b,c   Creuzot Garcher, C ^b,c   Bretillon, L ^b   Vergely, C ^a   Rochette, L ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b CENTRE DES SCIENCES DU GOÛT ET DE L ALIMENTATION   (France)

^c DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

Electroretinogram; HMGCoA reductase; Hypertension; NAD(P)H oxidase; Oxidative stress; Retina; Statin

Indexed keywords

CHOLESTEROL; HYDROETHIDINE; LIPID; PLASMALOGEN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; ROSUVASTATIN;

ANIMAL TISSUE; ARTICLE; B WAVE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ELECTRORETINOGRAM; ENZYME ACTIVITY; ENZYME ASSAY; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RETINA GANGLION CELL; SPONTANEOUSLY HYPERTENSIVE RAT; STAINING; WISTAR KYOTO RAT;

AGE FACTORS; ANIMALS; BLOOD PRESSURE; CHOLESTEROL, HDL; CHOLESTEROL, LDL; ELECTRORETINOGRAPHY; FLUOROBENZENES; HEART RATE; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; NADPH OXIDASE; OXIDATIVE STRESS; PLASMALOGENS; PYRIMIDINES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RETINA; RETINAL GANGLION CELLS; SOLUBILITY; SPECIES SPECIFICITY; SULFONAMIDES; SUPEROXIDES; WATER;

EID: 34547586417     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0707322     Document Type: Article

References (58)

1. Acar N, Chardigny JM, Bonhomme B, Almanza S, Doly M, Sebedio JL (2002). Long-term intake of trans (n-3) polyunsaturated fatty acids reduces the b-wave amplitude of electroretinograms in rats. J Nutr 132: 3151-3154.
2. Ackman RG (1981). Flame ionization detection applied to thin-layer chromatography on coated quartz rods. Methods Enzymol 72: 205-252.
3. Al-Shabrawey M, Bartoli M, El-Remessy AB, Platt DH, Matragoon S, Behzadian MA et al. (2005). Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy. Am J Pathol 167: 599-607.
4. Austin PC, Mamdani MM (2005). Impact of the pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22/Reversal of Atherosclerosis with Aggressive Lipid Lowering trials on trends in intensive versus moderate statin therapy in Ontario, Canada. Circulation 112: 1296-1300.
5. Bayorh MA, Ganafa AA, Eatman D, Walton M, Feuerstein GZ (2005). Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension. Am J Hypertens 18: 1496-1502.
6. Bellini G, Bocin E, Cosenzi A, Sacerdote A, Molino R, Solimano N et al. (1995). Oscillatory potentials of the electroretinogram in hypertensive patients. Hypertension 25: 839-841.
7. Bhutto IA, Amemiya T (1997). Vascular changes in retinas of spontaneously hypertensive rats demonstrated by corrosion casts. Ophthalmic Res 29: 12-23.
8. Block F, Schwarz M (1998). The b-wave of the electroretinogram as an index of retinal ischemia. Gen Pharmacol 30: 281-287.
9. Borghi C, Prandin MG, Costa FV, Bacchelli S, Degli Esposti D, Ambrosioni E (2000). Use of statins and blood pressure control in treated hypertensive patients with hypercholesterolemia. J Cardiovasc Pharmacol 35: 549-555.
10. Brosche T, Kral C, Summa JD, Platt D (1996). Effective lovastatin therapy in elderly hypercholesterolemic patients - an antioxidative impact? Arch Gerontol Geriatr 22: 207-221.
11. Bui BV, Fortune B (2004). Ganglion cell contributions to the rat fullfield electroretinogram. J Physiol 555: 153-173.
12. Chemtob S, Hardy P, Abran D, Li DY, Peri K, Cuzzani O et al. (1995). Peroxide-cyclooxygenase interactions in postasphyxial changes in retinal and choroidal hemodynamics. J Appl Physiol 78: 2039-2046.
13. Cingolani C, Rogers B, Lu L, Kachi S, Shen J, Campochiaro PA (2006). Retinal degeneration from oxidative damage. Free Radic Biol Med 40: 660-669.
14. Ciulla TA, Amador AG, Zinman B (2003). Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies. Diabetes Care 26: 2653-2664.
15. Davignon J (2004). Beneficial cardiovascular pleiotropic effects of statins. Circulation 109: III39-III43.
16. Doly M, Droy-Lefaix MT, Braquet P (1993). Retinal electrophysiology and retinotoxicity. In: Ferradini C, MD-L, Christen Y (eds). Advances in Ginkgo biloba Extract Research: Ginkgo biloba Extract (EGb 761) as a Free-Radical Scavenger. Paris, France, pp 61-71.
17. Dosso AA, Leuenberger PM, Rungger-Brandle E (1999). Remodeling of retinal capillaries in the diabetic hypertensive rat. Invest Ophthalmol Vis Sci 40: 2405-2410.
18. Du Y, Miller CM, Kern TS (2003). Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radic Biol Med 35: 1491-1499.
19. Engelmann B (2004). Plasmalogens: targets for oxidants and major lipophilic antioxidants. Biochem Soc Trans 32: 147-150.
20. Erdos B, Snipes JA, Tulbert CD, Katakam P, Miller AW, Busija DW (2006). Rosuvastatin improves cerebrovascular function in Zucker obese rats by inhibiting NAD(P)H oxidase-dependent superoxide production. Am J Physiol Heart Circ Physiol 290: H1264-H1270.
21. Ferrier KE, Muhlmann MH, Baguet JP, Cameron JD, Jennings GL, Dart AM et al. (2002). Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension. J Am Coll Cardiol 39: 1020-1025.
22. Folch J, Lees M, Sloane Stanley GH (1957). A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226: 497-509.
23. Glorioso N, Troffa C, Filigheddu F, Dettori F, Soro A, Parpaglia PP et al. (1999). Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia. Hypertension 34: 1281-1286.
24. Grech E, Dodd N, Jackson M, Morrison W, Faragher E, Ramsdale D (1996). Evidence for free radical generation after primary percutaneous transluminal coronary angioplasty recanalization in acute myocardial ischemia. Am J Cardiol 77: 122-127.
25. Griendling KK, Sorescu D, Ushio-Fukai M (2000). NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86: 494-501.
26. Halliwell B, Zhao K, Whiteman M (1999). Nitric oxide and peroxynitrite. The ugly, the uglier and the not so good: a personal view of recent controversies. Free Radic Res 31: 651-669.
27. Hirose F, Kiryu J, Miyamoto K, Nishijima K, Miyahara S, Katsuta H et al. (2004). In vivo evaluation of retinal injury after transient ischemia in hypertensive rats. Hypertension 43: 1098-1102.
28. Ikeda K, Negishi H, Yamori Y (2003). Antioxidant nutrients and hypoxia/ischemia brain injury in rodents. Toxicology 189: 55-61.
29. Jeffrey BG, Mitchell DC, Gibson RA, Neuringer M (2002). n-3 fatty acid deficiency alters recovery of the rod photoresponse in rhesus monkeys. Invest Ophthalmol Vis Sci 43: 2806-2814.
30. Klein R, Klein BE, Moss SE (1997). The relation of systemic hypertension to changes in the retinal vasculature: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc 95: 329-348; discussion 348-350.
31. Ko ML, Peng PH, Ma MC, Ritch R, Chen CF (2005). Dynamic changes in reactive oxygen species and antioxidant levels in retinas in experimental glaucoma. Free Radic Biol Med 39: 365-373.
32. Kortuem K, Geiger LK, Levin LA (2000). Differential susceptibility of retinal ganglion cells to reactive oxygen species. Invest Ophthalmol Vis Sci 41: 3176-3182.
33. Luhmann UF, Lin J, Acar N, Lammel S, Feil S, Grimm C et al. (2005). Role of the Norrie disease pseudoglioma gene in sprouting angiogenesis during development of the retinal vasculature. Invest Ophthalmol Vis Sci 46: 3372-3382.
34. Machida S, Kondo M, Jamison JA, Khan NW, Kononen LT, Sugawara T et al. (2000). P23H rhodopsin transgenic rat: correlation of retinal function with histopathology. Invest Ophthalmol Vis Sci 41: 3200-3209.
35. McGwin Jr G, McNeal S, Owsley C, Girkin C, Epstein D, Lee PP (2004). Statins and other cholesterol-lowering medications and the presence of glaucoma. Arch Ophthalmol 122: 822-826.
36. McGwin Jr G, Xie A, Owsley C (2005). The use of cholesterol-lowering medications and age-related macular degeneration. Ophthalmology 112: 488-494.
37. Mooradian AD, Haas MJ, Batejko O, Hovsepyan M, Feman SS (2005). Statins ameliorate endothelial barrier permeability changes in the cerebral tissue of streptozotocin-induced diabetic rats. Diabetes 54: 2977-2982.
38. Moreno MC, Campanelli J, Sande P, Sanez DA, Keller Sarmiento MI, Rosenstein RE (2004). Retinal oxidative stress induced by high intraocular pressure. Free Radic Biol Med 37: 803-812.
39. Niu SL, Mitchell DC, Lim SY, Wen ZM, Kim HY, Salem Jr N et al. (2004). Reduced G protein-coupled signaling efficiency in retinal rod outer segments in response to n-3 fatty acid deficiency. J Biol Chem 279: 31098-31104.
40. Otto A, Fontaine D, Fontaine J, Berkenboom G (2005). Rosuvastatin treatment protects against nitrate-induced oxidative stress. J Cardiovasc Pharmacol 46: 177-184.
41. Oudot A, Martin C, Busseuil D, Vergely C, Demaison L, Rochette L (2006). NADPH oxidases are in part responsible for increased cardiovascular superoxide production during aging. Free Radic Biol Med 40: 2214-2222.
42. Rodriguez-Iturbe B, Zhan CD, Quiroz Y, Sindhu RK, Vaziri ND (2003). Antioxidant-rich diet relieves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats. Hypertension 41: 341-346.
43. Rogers LJ, Bolden SW, Patrech AS, Ehrlich D (1993). Visual dysfunction in the spontaneously hypertensive rat. Physiol Behav 54: 903-907.
44. Sagar S, Kallo IJ, Kaul N, Ganguly NK, Sharma BK (1992). Oxygen free radicals in essential hypertension. Mol Cell Biochem 111: 103-108.
45. SanGiovanni JP, Chew EY (2005). The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res 24: 87-138.
46. Schiffrin EL, Park JB, Intengan HD, Touyz RM (2000). Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation 101: 1653-1659.
47. Sen K, Misra A, Kumar A, Pandey RM (2002). Simvastatin retards progression of retinopathy in diabetic patients with hypercholesterolemia. Diabetes Res Clin Pract 56: 1-11.
48. Sicard P, Lauzier B, Oudot A, Busseuil D, Collin B, Duvillard L et al. (2005). A treatment with rosuvastatin induced a reduction of arterial pressure and a decrease of oxidative stress in spontaneously hypertensive rats. Arch Mal Coeur Vaiss 98: 804-808.
49. Sicard P, Oudot A, Guilland JC, Moreau D, Vergely C, Rochette L (2006). Dissociation between vascular oxidative stress and cardiovascular function in Wistar Kyoto and spontaneously hypertensive rats. Vascul Pharmacol 45: 112-121.
50. Susic D, Varagic J, Ahn J, Slama M, Frohlich ED (2003). Beneficial pleiotropic vascular effects of rosuvastatin in two hypertensive models. J Am Coll Cardiol 42: 1091-1097.
51. Szabo ME, Droy-Lefaix MT, Doly M (1992). Modification of reperfusion-induced ionic imbalance by free radical scavengers in spontaneously hypertensive rat retina. Free Radic Biol Med 13: 609-620.
52. Touyz RM (2004). Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 44: 248-252.
53. Tzekov R, Arden GB (1999). The electroretinogram in diabetic retinopathy. Surv Ophthalmol 44: 53-60.
54. Wachtmeister L (1998). Oscillatory potentials in the retina: what do they reveal. Prog Retin Eye Res 17: 485-521.
55. Wilson HL, Schwartz DM, Bhatt HR, McCulloch CE, Duncan JL (2004). Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration. Am J Ophthalmol 137: 615-624.
56. Wong TY, McIntosh R (2005). Hypertensive retinopathy signs as risk indicators of cardiovascular morbidity and mortality. Br Med Bull 73-74: 57-70.
57. Yu T, Mitchell P, Berry G, Li W, Wang JJ (1998). Retinopathy in older persons without diabetes and its relationship to hypertension. Arch Ophthalmol 116: 83-89.
58. Zoeller RA, Morand OH, Raetz CR (1988). A possible role for plasmalogens in protecting animal cells against photosensitized killing. J Biol Chem 263: 11590-11596.